Revenue segments as reported by the company.

Product and equipment sales

Service and lease sales

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Special (gains) and charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Ecolab

Ecolab, Inc. engages in the provision of products and services in the field of water, hygiene, and energy. It operates through the following segments: Global Industrial, Global Institutional & Specialty, Global Energy & Life Science, and Other. The Global Industrial segment consists of the water, food and beverage, paper, and downstream operating segments. It offers water treatment and process applications, and cleaning and sanitizing solutions to industrial customers within the manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, pulp and paper, commercial laundry, global petroleum, and petrochemical industries. The Global Institutional & Specialty segment consists of the institutional, specialty and healthcare operating segments. It provides cleaning and sanitizing products to the foodservice, hospitality, lodging, healthcare, government, education, and retail industries. The Global Healthcare & Life Sciences segment includes the healthcare and life sciences operations. It provides cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries. The Other segment includes Pest Elimination operations, which provide services to detect, eliminate and prevent pests, such as rodents and insects, CTG operations, which produce and sell colloidal silica, which is comprised of nano-sized particles of silica in water used for binding and polishing applications, and Textile Care operations, which provide products and services that manage the entire wash process through custom designed programs, premium products, dispensing equipment, water and energy management and reduction, and real time data management. The company was founded by Merritt J. Osborn in 1923 and is headquartered in St. Paul, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Ecolab exceeds Q4 expectations, eyes growth in China and water management

Ecolab's strong Q4 performance, focus on innovation and margin improvement, and confidence in navigating challenges position the company for continued growth. Opportunities in managing PFAS in water, growth in China, and cost reduction solutions offer avenues for future expansion. Challenges from cost inflation and softening interest rates require strategic management.

Ecolab reports robust Q1 performance, eyes growth amid challenges

Ecolab's Q1 2023 performance reflects strength in sales growth, margin expansion, and strategic initiatives across segments.
While facing challenges like seasonality and margin volatility, the company is well-positioned to capitalize on growth opportunities.
Key strengths include pricing execution, SG&A productivity, and market share gains, with a focus on innovation and sustainability.
Navigating high inflation and geopolitical tensions, Ecolab remains committed to capital stewardship and delivering value to shareholders.

Ecolab reports robust Q2 earnings, eyes growth amid restructuring

Ecolab's Q2 performance reflects strong sales growth and earnings, with a focus on innovation and margin improvement. While facing challenges in healthcare restructuring and pricing dynamics, the company is well-positioned for future growth through digital investments and operational enhancements.

Ecolab reports robust Q3 earnings, eyes growth in healthcare and technology

Ecolab's Q3 performance showcased strong sales growth, margin expansion, and a positive outlook for future earnings. The company is strategically addressing challenges in healthcare, hospitality, and inventory management. Opportunities lie in segment separations, industry growth trends, and technological advancements.

Ecolab posts robust Q4 results, eyes margin expansion for growth

Ecolab's strong performance in Q4 2023 underscores its strategic focus on margin improvement and growth. With a clear roadmap for margin expansion and earnings growth, the company is well-positioned for future success.

Ecolab reports robust Q1 results, eyes digital growth opportunities

Ecolab's Q1 performance reflects strong growth and margin expansion across segments, with a positive outlook for the full year. By focusing on customer value, strategic changes, and digital capabilities, Ecolab aims to sustain its long-term growth trajectory amidst challenges in certain business segments.

Ecolab reports robust Q2 earnings, sets ambitious growth targets

Ecolab's Q2 performance showcased strong earnings growth, margin expansion, and solid organic sales. The company's One Ecolab initiative aims for sustainable growth and margin improvement. Despite challenges from the sale of a business unit and FX headwinds, Ecolab remains focused on driving shareholder value and strategic investments.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Ecolab, Inc. engages in providing products and services in the field of water, hygiene, and energy. It operates through the following segments: Global Industrial, Global Institutional and Specialty, Global Energy and Life Science, and Other. The Global Industrial segment relates to water, food and beverage, paper, and downstream operating segments. The Global Institutional and Specialty segment refers to the institutional, specialty, and healthcare operating segments. The Global Healthcare and Life Sciences segment includes the healthcare and life sciences operations. The Other segment is involved in providing services to detect, eliminate and prevent pests. The company was founded by Merritt J. Osborn in 1923 and is headquartered in St. Paul, MN.

Expected sales growth across segments, product innovation and accelerating pricing are likely to aid Ecolab (ECL) in Q1. However, forex might play spoilsport.

Can Global Industrial Unit Fuel Ecolab's (ECL) Q1 Earnings?

A solid guidance for 2019 and broad product spectrum will provide Ecolab (ECL) a competitive edge in the MedTech space.

Here's Why You Should Retain Ecolab Stock in Your Portfolio

News for Ecolab Stock (ECL)